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E-mail: sudat@kenroku.kanazawa-u.ac.jpThe adaptor protein ASC (also called TMS1) links certain NLR pro-
teins (e.g., NLRC4, NLRP3) and caspases. It is involved in the
chemosensitivity of tumor cells and inflammation. Here, we found
that ASC activation using NLRC4 mimicry or an autoinflammatory
disease-associated NLRP3 mutant induced necrosis in COLO205
colon adenocarcinoma cells, but induced caspase-8-dependent
apoptosis in NUGC-4 stomach cancer cells. As the Fas ligand
induced caspase-8-dependent apoptosis in COLO205 cells, caspase-
8 was intact in this cell line. ASC-mediated necrosis was preceded
by lysosomal leakage, and diminished by inhibitors for vacuolar
H+-ATPase, cathepsins, and calpains but not by inhibitors for cas-
pase-8, or aspartic proteases, suggesting that lysosomes and cer-
tain proteases were involved in this process. Finally, growing
tumors of transplanted human cancer cells in nude mice were
eradicated by the activation of endogenous ASC in the tumor cells,
irrespective of the form of cell death. Thus, ASC mediates distinct
forms of cell death in different cell types, and is a promising target
for cancer therapy. (Cancer Sci 2010; 101: 1822–1827)
T he adaptor protein ASC was originally identified as a pro-tein that forms large aggregates in HL-60 human leukemia
cells treated with chemotherapeutic agents,(1) and as the product
of a gene that is silenced in cancer cells by DNA methylation.(2)
ASC interacts with NLRC4 (also called CARD12, IPAF, or
CLAN), a caspase recruitment domain (CARD)-containing
member of the NLR family, through a homophilic interaction
between the CARDs, and mediates intracellular signals for
apoptosis and nuclear factor-jB activation.(3–5) In addition, the
genes for ASC and NLRC4 are targets of p53 and are required
for the apoptosis induced by p53 and chemotherapeutic
drugs.(6,7) Thus, the NLRC4–ASC axis seems to be important
for tumor suppression and the chemosensitivity of cancer cells.
However, the potential of ASC as a molecular target for cancer
therapy has not been evaluated.
Another line of research revealed that ASC functions as an
adaptor protein that recruits caspase-1 to several pyrin domain-
containing members of the NLR family, such as NLRP3 (also
called PYPAF1, cryopyrin, or NALP3).(8) NLRP3 serves as a
sensor for cell-invading pathogens(9,10) or various inflammatory
substances, such as uric acid crystals(11) and asbestos.(12) Thus,
ASC plays an essential role in the caspase-1-dependent matura-
tion of pro-inflammatory cytokines such as interleukin (IL)-1b
and IL-18 in response to these inflammatory stimuli. In addition,
disease-associated NLRP3 mutations that are responsible for
familial autoinflammatory syndromes cause aberrant ASC-
dependent caspase-1 activation and IL-1b secretion.(13) NLRC4
also functions as a sensor for certain cell-invading bacteria such
as Salmonella typhimurium, and ASC is required for the NLRC4-
dependent caspase-1 activation and IL-1b secretion.(14) In mouse
macrophages, the caspase-1 activation induced by S. typhimuri-
um causes a unique form of cell death called pyroptosis.(15)Cancer Sci | August 2010 | vol. 101 | no. 8 | 1822–1827We previously showed that the activation of ASC using
NLRC4 mimicry induces caspase-8-dependent apoptosis in
human cancer cell lines.(5) However, recent studies show
that the exogenous expression of disease-associated NLRP3
mutants or the activation of endogenous wild-type NLRP3 by
bacterial infection induces necrosis in an ASC-dependent man-
ner in human monocytic leukemia THP-1 cells.(16) This necro-
sis (called pyronecrosis) is inhibited by the cathepsin B
inhibitor CA-074Me;(16,17) however, the precise mechanism of
this necrosis and the reason ASC induces different forms of
cell death (apoptosis or necrosis) in different contexts are
unknown.
In this study, we investigated the types of cell death induced
by the activation of ASC using NLRC4 mimicry or NLRP3
mutants in two cancer cell lines, and showed that the cell type,
rather than the means of activating ASC, determines whether
cells die by apoptosis or necrosis. We also showed for the first
time that the activation of ASC in tumors results in tumor
eradication, irrespective of the type of cell death.
Materials and Methods
Reagents. Soluble mouse Fas ligand was prepared as
described previously.(18) Muramyl dipeptide (MDP; Sigma, St
Louis, MO, USA), Z-IETD-fluoromethylketone (Z-IETD-FMK;
R&D Systems, Minneapolis, MN, USA), CA-074Me, cathepsin
L inhibitor IV, cathepsin S inhibitor, calpain inhibitor XI
(Merck Calbiochem, Tokyo, Japan), pepstatin A (Peptide Insti-
tute, Minoh, Osaka, Japan) and bafilomycin A (Fermentek,
Jerusalem, Israel) were purchased.
To generate an anti-human ASC mAb, lymph node cells from
a BALB ⁄ c mouse immunized with human ASC (amino acids
113–195) were fused with P3U1 mouse myeloma cells. Hybrid-
oma clones producing mAb that detected human ASC expressed
in HEK293 cells by Western blotting were selected. The mAb
purified from the hybridoma clone 71 was used in this study.
Anti-caspase-8 mAb (MBL, Nagoya, Japan), anti-cathepsin B
polyclonal Ab (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), anti-b-actin mAb (Sigma), and anti-GAPDH mAb (Milli-
pore, Billerica, MA, USA) were purchased.
Plasmids. The expression plasmids for Flag-C12N2 (pEF-
Flag-C12N2) and NLRP3 (pEF-PYPAF1) were described previ-
ously.(4,19) The expression plasmid for the NLRP3-Y570C
mutant in the pEF-BOS vector was provided by Dr. Naotomo
Kambe (Chiba University, Chiba, Japan).(17) To generate lentivi-doi: 10.1111/j.1349-7006.2010.01610.x
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ral vectors expressing NLRP3 or NLRP3-Y570C, the GFP
cDNA in pLVCT-tTR-KRAB (Addgene, Cambridge, MA) was
replaced by the corresponding cDNA.
Human cell lines. The NUGC-4 stomach cancer and
COLO205 colon adenocarcinoma cell lines were obtained from
the Cell Resource Center for Biomedical Research (Tohoku
University, Sendai, Japan). The NUC12N2 cell line was
described previously.(5) To generate the CLC12N2 cell line,
COLO205 cells were cotransfected with pEF-FLAG-C12N2 and
a vector carrying the puromycin-resistance gene. Among the
puromycin-resistant clones, those that underwent cell death
upon stimulation with MDP were established as stable cell lines.
Mice. Six-week-old female BALB ⁄ c and KSN nu ⁄nu mice
were purchased from SLC (Shizuoka, Japan). The Kanazawa
University Committee on Animal Welfare approved all animal
protocols.
Apoptosis and necrosis assay. The proportions of apoptotic
and necrotic cells were determined by flow cytometry after
staining the cells with propidium iodide (Sigma) and Cy5–
annexin V (Biovision, Mountain View, CA, USA), as described
previously.(5) Cell viability was assessed by WST-1 assay as
described previously.(20) When cells were transduced with len-
tiviral vectors, the proportions of apoptotic and necrotic cells
were determined in situ as described below. Hoechst 33342
(ABD Bioquest, Sunnyvale, CA, USA) and propidium iodide
(both 2.5 lg ⁄mL) were added to the culture wells at the end of
transduction. After an additional 30-min incubation, the apopto-
tic cells (showing nuclear condensation and ⁄or fragmentation(a) (
(b) (d)
Fig. 1. Activation of ASC induces apoptosis and necrosis, depending on
dipeptide (MDP; 100 ng ⁄mL) for 8 h (NUGC-4 and NUC12N2 cells) or 6 h
under a microscope. Scale line = 20 lm. (b) Cells were cultured without (
cells), stained with Cy5–annexin V and propidium iodide, and analyzed b
iodide), Cy5–annexin V+) or necrotic cells (propidium iodide+) are in
(100 ng ⁄mL) for the indicated period, and analyzed as described in (b). T
were plotted. (d) Cells were transfected with control (cont) or ASC-targ
(100 ng ⁄mL) for the last 16 h (NUC12N2) or 8 h (CLC12N2) of a 72-h cultu
GAPDH at the end of the 72-h culture period without MDP were examin
cells were transduced with a lentiviral vector for wild-type (WT) or Y57
Hoechst 33342 and propidium iodide. The percentages of apoptotic cells (
in duplicate, and error bars represent the range of the duplicate data.
Motani et al.revealed by Hoechst 33342 staining) and necrotic cells (stained
by propidium iodide without nuclear condensation) were
counted under a fluorescence microscope (Keyence, Osaka,
Japan). More than 500 cells in five fields were examined.
Acridine orange staining. Cells were stained with acridine
orange (1 lg ⁄mL; Wako Pure Chemical Industries, Osaka,
Japan) for 30 min. Acridine orange absorbs light at approxi-
mately 490 nm and emits red fluorescence (600–650 nm) under
acidic conditions, especially in lysosomes. The red fluorescence
of the acridine orange was analyzed by flow cytometry.
Transfection of genes and siRNAs. NUC12N2 cells were
transfected with siRNA (100 nM) using RNAiMAX (Invitrogen,
Tokyo, Japan). CLC12N2 cells were transfected with siRNA
(20 nM) using the Neon Transfection System (Invitrogen). The
ASC-targeting siRNA (Stealth Select HSS147065) and the cas-
pase-8-targeting siRNA (Stealth siRNA HSS141460) were pur-
chased from Invitrogen. For viral transduction, the target cells
were seeded into a 96-well plate, and the viral supernatant was
added to the cells together with 10 lg ⁄mL polybrene. The cul-
ture plate was centrifuged at 1200g for 60 min at room tempera-
ture to improve the transduction efficiency.
Cancer therapy models. KSN nu ⁄nu mice were injected s.c.
in the dorsal region with 2.5 · 106 tumor cells. MDP (200 lg)
was given to the mice i.v. on days 5 and 8 after the tumor injec-
tion. The long and short diameters of the tumors were measured
at 3-day intervals using a hand-held caliper. The tumor size was
calculated as follows. Tumor size (mm2) = long diameter
(mm) · short diameter (mm). For the peritoneally disseminatedc)
(e)
the cell type. (a) Cells were cultured without ()) or with muramyl
(COLO205 and CLC12N2 cells). Morphological changes were observed
)) or with MDP (100 ng ⁄mL) for 8 h (NUC12N2 cells) or 6 h (CLC12N2
y flow cytometry. The percentages of early apoptotic cells (propidium
dicated. (c) CLC12N2 and NUC12N2 cells were cultured with MDP
he percentages of apoptotic NUC12N2 cells and necrotic CLC12N2 cells
eting siRNA. The cells were then incubated without ()) or with MDP
re, and analyzed as described in (b). The expression levels of ASC and
ed by Western blot analysis (lower panels). (e) NUGC-4 and COLO205
0C mutant NLRP3. After culture for 12 h, the cells were stained with
Apo) and necrotic cells (Nec) are indicated. Experiments c–e were done
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tumor model, 2.5 · 106 NUC12N2 cells were injected i.p. into
KSN nu ⁄nu mice. Three and 10 days after the tumor inocula-
tion, MDP (200 lg) was given to the mice i.p. Forty-nine days
after the tumor inoculation, the mice were killed and the devel-
opment of ascites and peritoneal nodules was examined.
Results
Necrotic or apoptotic cell death induced by ASC, depending on
the cell type. To investigate the functions of ASC in cells, we
previously established an experimental system in which a chi-
meric protein (C12N2) consisting of the CARD from NLRC4
and the nucleotide-binding oligomerization domain (NOD) and
leucine-rich repeats from NOD2 (also called NLRC2), a sensor
for MDP, was expressed in cells.(4) In this system, the simple
addition of MDP to the culture medium induced ASC-dependent
responses in the cells. Using this system, we previously showed
that the activation of ASC induces caspase-8-dependent apopto-
sis in stomach, colon, and lung cancer cell lines.(5)
Here, we generated another stable C12N2 transfectant cell
line, CLC12N2, from the COLO205 colon adenocarcinoma cell
line. Unexpectedly, the MDP-induced cell death was associated
with cell swelling in CLC12N2 cells (Fig. 1a). MDP did not
induce death in the parental cell line. Flow cytometry analyses
after fluorochrome-conjugated annexin V and propidium iodide
staining indicated that MDP induced rapid plasma membrane
permeabilization without the preceding externalization of phos-(a) (b)
(d) (e)
Fig. 2. Caspase-8 is not required for ASC-mediated necrosis. (a) The e
COLO205, NUC12N2, and CLC12N2 cells were examined by Western blo
dipeptide (MDP; 100 ng ⁄mL) for the indicated period. Pro-caspase-8 and
blot analysis using an anti-caspase-8 Ab. (c) CLC12N2 cells were treated wi
()) for 8 h. (d) CLC12N2 cells were cultured in the presence or absence (D
without ()) or with MDP (100 ng ⁄mL) for the last 6 h or FasL (1000 U ⁄mL
with control, ASC-targeting, or caspase-8-targeting siRNA. Cells were
untreated ()) for the last 6 h of a 48-h culture. The expression levels o
stimuli were examined by Western blotting (right panels). (c–e) The cult
done in duplicate, and error bars in (d,e) represent the range of the dupli
1824phatidylserine on the cell surface, showing that the CLC12N2
cells underwent necrosis (Figs 1b and S1). In contrast, consis-
tent with our previous data,(5) when NUC12N2 cells, a stable
C12N2 transfectant derived from the NUGC-4 stomach cancer
cell line, were treated with MDP, typical apoptosis was induced,
as revealed by the extensive blebbing of the dying cells (Fig. 1a)
and the externalization of phosphatidylserines preceding per-
meabilization of the plasma membrane (Figs 1b and S1). The
MDP-induced necrosis in CLC12N2 cells was more rapid than
the apoptosis in NUC12N2 cells (Fig. 1c). The reduction of
ASC expression by RNAi abrogated the MDP-induced apoptosis
in NUC12N2 cells and necrosis in CLC12N2 cells (Fig. 1d),
confirming that both types of cell death were mediated by ASC.
It was recently reported that disease-associated mutants of
NLRP3 induce ASC-dependent necrotic cell death in the THP-1
human monocytic leukemia cell line,(16) so we investigated
whether such an NLRP3 mutant (Y570C) induced necrosis or
apoptosis in COLO205 and NUGC-4. The viral transduction of
mutant but not wild-type NLRP3 induced significant necrosis
and apoptosis in COLO205 and NUGC-4 cells, respectively
(Figs 1e and S2). These results indicate that the activation of
ASC induces either necrosis or apoptosis, depending on the cell
type rather than on the upstream molecular machinery used to
activate ASC.
Caspase-8 in CLC12N2 cells intact but not required for ASC-
mediated necrosis. We previously showed that caspase-8 is the
initiator caspase for ASC-mediated apoptosis.(5) Therefore, we(c)
xpression levels of ASC, caspase-8 (Casp8), and GAPDH in NUGC-4,
tting. (b) NUC12N2 and CLC12N2 cells were cultured with muramyl
the large subunit of mature caspase-8 (p20) were detected by Western
th MDP (100 ng ⁄mL) or Fas ligand (FasL; 1000 U ⁄mL), or left untreated
MSO) of 40 lM Z-IETD-fluoromethylketone (IETD) for 7 h and treated
) for the last 4 h of the 7-h culture. (e) CLC12N2 cells were transfected
cultured with MDP (100 ng ⁄mL) or Fas ligand (1000 U ⁄mL), or left
f ASC, caspase-8, and GAPDH at the end of the 48-h culture without
ured cells were analyzed as described in Figure 1b. Experiments were
cate data.
doi: 10.1111/j.1349-7006.2010.01610.x
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(a) (b)
(c)
Fig. 3. Necrotic cell death is prevented by cathepsin B inhibitor CA-
074Me. (a) The expression levels of cathepsin B (CathepB) and GAPDH
in NUGC-4, COLO205, NUC12N2, and CLC12N2 cell lines were
examined by Western blotting. (b,c) The CLC12N2 cells were
pretreated with the indicated inhibitors for 1 h, then stimulated with
muramyl dipeptide (MDP; 100 ng ⁄mL) for 8 h. The cell viability was
assessed by WST-1 assay. Experiments were done in duplicate, and





Fig. 4. Lysosomal leakage is involved in ASC-mediated necrosis. (a)
CLC12N2 cells stimulated with muramyl dipeptide (MDP; 100 ng ⁄mL)
for the indicated period were stained with acridine orange, and the
red fluorescence was measured by flow cytometry (solid line). The
dotted line indicates unstimulated cells. (b) CLC12N2 cells were
pretreated with or without bafilomycin A1 (10 nM) or CA-074Me
(80 lM) for 1 h, then cultured in the presence or absence of MDP
(100 ng ⁄mL) for 3 h. The cells were stained with acridine orange and
analyzed as described in (a). The dotted line indicates unstimulated
cells. (c) CLC12N2 cells were pretreated with the indicated
concentrations of bafilomycin A1 for 1 h, then stimulated without ())
or with MDP (100 ng ⁄mL) for 8 h. The cell viability was assessed by
WST-1 assay. Experiments were done in duplicate, and error bars
represent the range of the duplicate data.investigated the expression and function of caspase-8 in
NUC12N2 and CLC12N2 cells. Western blot analyses revealed
that the expression levels of caspase-8 and ASC in NUC12N2,
CLC12N2, and their parental cell lines were comparable
(Fig. 2a). Consistent with our previous finding that the ASC-
mediated apoptosis in NUC12N2 cells is caspase-8 dependent,(5)
the generation of the large subunit (p20) of mature caspase-8
was observed in this cell line upon MDP stimulation (Fig. 2b).
In contrast, the generation of p20 was not observed in CLC12N2
cells, even 4 h after MDP stimulation (Fig. 2b), when most of
the cells showed a necrotic morphology (Fig. 1c).
It has also been reported that apoptotic stimuli can induce
necrotic cell death in certain types of cells, especially when the
caspase activity is inhibited,(21) so we next investigated whether
caspase-8 function was intact in CLC12N2 cells. Intriguingly,
Fas ligand induced typical apoptosis in CLC12N2 cells, whereas
MDP induced necrosis under the same conditions (Fig. 2c).
Importantly, the Fas ligand-induced apoptosis of CLC12N2 cells
was inhibited by the caspase-8 inhibitor Z-IETD-FMK, whereas
this inhibitor neither enhanced nor inhibited the MDP-induced
necrosis of the same cell line (Fig. 2d). Consistent with this find-
ing, the reduction of caspase-8 expression by RNAi inhibited
the Fas ligand-induced apoptosis but not the MDP-induced
necrosis of CLC12N2 cells, but the reduction of ASC did the
opposite (Fig. 2e). These results indicate that the caspase-8
function in CLC12N2 cells is intact, but is not involved in ASC-
mediated necrosis.
Inhibitors for cathepsin B, L, and S, and calpains abrogate ASC-
mediated necrosis. The necrosis of THP-1 cells induced by dis-
ease-associated NLRP3 mutants is inhibited by a cathepsin B
inhibitor, CA-074Me.(16,17) Therefore, we next addressed thatMotani et al.cathepsin B was responsible for the ASC-mediated necrotic cell
death in our experimental system. Cathepsin B protein was
expressed in COLO205 and CLC12N2 cells but not in NUGC-4
or NUC12N2 cells (Fig. 3a). Furthermore, MDP-induced necro-
sis of CLC12N2 cells was reduced dose-dependently by CA-
074Me but not by Z-IETD-FMK (Fig. 3b). This necrosis was
also diminished by inhibitors for cathepsins L and S, and cal-
pains (calpain-1 and calpain-2), but not by pepstatin A, an inhib-
itor of aspartic proteases (Fig. 3c). However, the knockdown of
cathepsin B expression by RNAi failed to inhibit the MDP-
induced necrosis of CLC12N2 cells (Fig. S3). These results sug-
gest that a protease cascade that includes cathepsins and calpains
is redundantly involved in ASC-mediated necrosis.
Lysosomes involved in ASC-mediated necrosis. It was previ-
ously shown that, during the course of THP-1 cell death induced
by disease-associated NLRP3 mutants, ‘‘small-scale lysosomal
leakage (SSLL)’’ was observed as a reduction of red fluores-
cence in cells stained with acridine orange.(17) Therefore, weCancer Sci | August 2010 | vol. 101 | no. 8 | 1825
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stimulated acridine orange-stained CLC12N2 cells with MDP
and monitored the red fluorescence by flow cytometry. Consis-
tent with the previous report, a portion of the CLC12N2 cells
showed a slight reduction in red fluorescence, corresponding to
SSLL, 3 h after the addition of MDP (Fig. 4a). Four hours after
the MDP addition, corresponding to necrosis, a large population
of the cells showed a dramatic reduction in red fluorescence
(Fig. 4a). Thus, SSLL appeared to precede necrosis. Further-
more, CA-074Me inhibited the MDP-induced SSLL (Fig. 4b).
These observations were strikingly similar to those reported for
THP-1 cells expressing the NLRP3 mutants, suggesting that the
activation of ASC induces a similar form of cell death in
COLO205 and THP-1 cells. In addition, we found that the vacu-
olar ATPase (v-ATPase) inhibitor bafilomycin A1 abrogated
the MDP-induced SSLL (Fig. 4b) and necrosis (Fig. 4c) in
CLC12N2 cells. Collectively, these results suggest that the
v-ATPase-dependent acidification of lysosomes and the sub-
sequent activation of cathepsins are involved in the SSLL and
necrosis of MDP-treated CLC12N2 cells.
Potential molecular target for cancer therapy. Finally, we
investigated whether the activation of ASC could lead to tumor
eradication in vivo. For this purpose, NUC12N2 or CLC12N2
cells or their parental lines were transplanted intradermally into
the back of nude mice. After tumor nodules larger than 5 mm in
diameter were established, 200 lg MDP was injected i.v.
Remarkably, both the NUC12N2 and CLC12N2 tumors were
completely eradicated after MDP injection, whereas the tumors
derived from the parental cell lines kept growing, irrespective of
treatment with PBS or MDP (Fig. 5a). The injection of as little
as 50 lg MDP induced the almost complete eradication of the
NUC12N2 tumors (Fig. S4). Because NUGC-4 is a stomach
cancer cell line, we also tested whether MDP treatment was
effective for peritoneally disseminated tumor cells. Mice that
received a PBS injection 3 days after the intraperitoneal injec-
tion of NUC12N2 tumor cells developed ascites and multiple
peritoneal nodules. In contrast, the four MDP-injected mice
developed no ascites, although tumor nodules were observed in
one of them (Fig. 5b). These results indicate that tumor cells can
be eradicated in vivo by activating ASC in them, irrespective of
the type of cell death induced by the activation of ASC.
Discussion
We previously showed that the activation of ASC using NLRC4
mimicry induces caspase-8-dependent apoptosis in various
human cancer cell lines, including the NUC12N2 stomach can-(a)
Fig. 5. ASC activation eradicates tumor cells in vivo. (a) NUGC-4, NU
intradermally into the back of nude mice (n = 4) on day 0. Muramyl dipep
and 8 (vertical arrows). Error bars indicate SD. (b) NUC12N2 cells (2.5 · 106
MDP (200 lg) or PBS was injected i.p. The upper panels show mice in a su
the mice receiving PBS but not in those receiving MDP. The lower table s
nodules on day 49.
1826cer cell line.(5) However, recent reports have indicated that the
activation of ASC by disease-associated mutants of NLRP3 or
Shigella flexneri infection, which triggers the NLRP3–ASC axis,
induces a type of necrotic cell death called pyronecrosis in
human monocytic leukemia THP-1 cells.(16) Therefore, we ini-
tially speculated that ASC leads to apoptosis or necrosis depend-
ing on its upstream effectors, that is, NLRC4 or NLRP3. Here,
however, we show that ASC activation, irrespective of its
upstream effectors, that is, NLRC4 mimicry or an NLRP3
mutant, induced caspase-8-independent necrosis in the
COLO205 colon adenocarcinoma cell line. In contrast, both
NLRC4 mimicry and the NLRP3 mutant induced apoptosis in
NUGC-4 cells. These results clearly indicated that the form of
ASC-mediated cell death is determined by cell type rather than
by upstream effector proteins.
The molecular mechanisms that determine the form of ASC-
mediated cell death are currently unclear. Tumor necrosis factor
(TNF), a well-known death factor that induces caspase-8-depen-
dent apoptosis, causes necrotic cell death in some cell types,
especially when caspase activity is inhibited. Recently, RIP3
was found to be a molecular switch for TNF-induced necro-
sis.(22–24) However, the function of caspase-8 and its pro-apopto-
tic downstream effectors were intact in the CLC12N2 cells,
given that Fas ligand induced caspase-8-dependent apoptosis in
this cell line. In addition, the caspase-8 inhibitor Z-IETD-FMK
neither enhanced nor inhibited the ASC-mediated necrosis of
CLC12N2 cells. Furthermore, the pan-caspase inhibitor Z-VAD-
FMK inhibited the ASC-mediated apoptosis of NUC12N2 cells,
but did not change the cell-death type from apoptosis to necrosis
(data not shown). These results suggest that ASC-mediated
necrosis is different from TNF-induced necrosis. Nevertheless,
it would be interesting to examine whether RIP3 is also required
for ASC-mediated necrosis.
The ASC-mediated necrosis of COLO205 cells in our system
was accompanied by SSLL and inhibited by the CA-074Me
cathepsin B inhibitor, which is consistent with a previous report
on the ASC-mediated necrosis of THP-1 cells. However, the
reduction of cathepsin B expression using RNAi did not sup-
press the ASC-mediated necrosis in COLO205 cells. Because
inhibitors for cathepsins L and S also inhibited the ASC-medi-
ated necrosis, multiple cathepsins seem to be redundantly
involved in this necrosis, and an inhibitor for one cathepsin
might cross-inhibit other cathepsins. Consistent with the
involvement of these lysosomal proteases, which show optimal
activity at acidic pH, the v-ATPase inhibitor bafilomycin A1
inhibited the ASC-mediated SSLL and necrosis. Thus, it is likely(b)
C12N2, COLO205, and CLC12N2 cells (2.5 · 106) were transplanted
tide (MDP; 200 lg) or control PBS was injected i.v. into mice on days 5
) were injected i.p. into nude mice (n = 4) on day 0. On days 3 and 10,
pine position on day 49. The accumulation of ascites was evident in all
hows the ratio of mice with ascite accumulation and peritoneal tumor
doi: 10.1111/j.1349-7006.2010.01610.x
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that lysosomal acidification followed by cathepsin activation
resulted in the SSLL and necrosis. We found that a calpain
inhibitor also blocked the ASC-mediated necrosis. Because
calpains are reported to be involved in the activation of cath-
epsins and lysosomal rupture in ischemic neuronal cell
death,(25) they may act upstream of cathepsins. A caveat is
that the calpain inhibitor used in the present study weakly
inhibits cathepsin B, so the observed reduction of necrosis by
this inhibitor might have been due to the cross-inhibition of
cathepsin B.
Although it has been shown that ASC is involved in the
chemosensitivity of cancer cells,(6) the potential of ASC as a
molecular target for cancer therapy has not been directly exam-
ined. In this study, we showed that the activation of ASC in
tumor cells, irrespective of the induced cell death type, caused
the complete eradication of intradermal solid tumors or of peri-
toneal disseminated tumor cells. Thus, ASC can be a molecular
target for cancer therapy. An interesting question is whether
apoptosis or necrosis is the preferable type of cell death forMotani et al.tumor eradication, with respect to cancer therapy. Both the
NUC12N2 (apoptosis-type) and CLC12N2 (necrosis-type)
tumors were equally and efficiently eradicated when ASC was
activated by MDP. However, because we used immune-incom-
petent mice as the host animals for human cancer cells, we could
not investigate the immunological aspects of ASC-mediated
cancer therapy. It would be interesting to compare the apopto-
sis-type and necrosis-type tumor cells in terms of the potency of
the antitumor immunity developed after ASC-targeted therapy,
using combinations of immune-competent mice and syngeneic
tumor cell lines.
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